miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review

Published:2024-03 Issue: Volume:37 Page:101588
ISSN:2405-5808
Container-title:Biochemistry and Biophysics Reports
language:en
Short-container-title:Biochemistry and Biophysics Reports

Author:

Vo Thanh Hoa^ORCID,EL-Sherbieny Abdelaal Esam,Jordan Emmet,O'Donovan Orla,McNeela Edel A.^ORCID,Mehta Jai Prakash,Rani Sweta^ORCID

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference107 articles.

1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2016

2. Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer;Witton;J. Pathol.,2003

3. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N. Engl. J. Med.,2011

4. Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance;Bailey;J. Carcinog.,2011

5. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat. Rev. Clin. Oncol.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer;Cancers;2024-07-24

2. Biological mechanisms of resistance to trastuzumab and ways to overcome them: Mod-ern problems of clinical oncology;Regulatory Mechanisms in Biosystems;2024-05-11

3. miRNA Signature and its Clinicopathological Association in Colorectal Cancer: A Cross-sectional Study;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP